Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Recombinant Transaminase Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN106801043B reveals high-efficiency enzymatic synthesis for Sitagliptin intermediates, offering superior purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN114075557B reveals enzymatic synthesis for high-purity Larotrectinib intermediate. Achieve cost reduction and scalable supply chain reliability.
Patent CN119530189A reveals green enzymatic route for cyclohexylamine. Offers high selectivity and reduced environmental impact for pharmaceutical intermediate supply chains.